OCEAN, said Albert, provides important risk-benefit data that doctors can now use in discussions with their patients. For ...
NEW ORLEANS, LA—Among patients with atrial fibrillation (AF) undergoing PCI, 1 month of dual therapy with a direct oral ...
The drug, given as a weekly subcutaneous injection, reduced both triglycerides and liver fat in the phase II trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback